Moreover, the HSV-TK/GCV suicide gene therapy strategy,mediated by PAMA144-co-PLAMA19-based nanocarriers, resulted in high antitumor activity in 2D and3D culture models of HCC, which was significantly enhanced by thecombination with small amounts of docetaxel. The gene discussed is TKT; the disease is hepatocellular carcinoma.